Patent · US Active

Method and pharmaceutical composition for use in the treatment of neurodegenerative disorders

US11313852B2 · kind B2 · utility

0Cited by

0References

2Claims

0Family size

Assignees

INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) · FR
CNRS-CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE · FR

Inventors

Ludivine Perrocheau · Paris, FR
Alain Van Dorsselaer · Paris, FR
Jose-Alain Sahel · Paris, FR
Thierry Leveillard · Maisons-Alfort, FR

Key dates

Filing date	Feb 20, 2017
Grant date	Apr 26, 2022
Priority date	—
Expiry date	Oct 3, 2037

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/28
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The invention relates to compounds which activate the BASIGIN signalling pathway, preferably agonists of BASIGIN, for the treatment of neurodegenerative disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.